Abstract:For the past 10 years we have been investigating the differential effects of genetic diversity on AIDS pathogenesis and HIV infection. In particular, we are interested in two highly polymorphic immunogenetic systems, namely human leukocyte antigen (HLA) and killer immunoglobulin-like receptor (KIR). The allelic polymorphism of HLA genes and chromosomal organization of KIR genes were characterized in multiple AIDS cohorts to examine their effects on AIDS progression and HIV-1 infection. HLA zygosity and three HLA-B alleles show a consistent association with AIDS: HLA-B*35Px shows a susceptible effect associated with a more rapid progression to AIDS, whereas HLA-B*27, B*57 and HLA heterozygosity show protective effects associated with a slower disease progression. Most immunogenetic effects are detected at the stage of CD4 T-cell depletion, but the B27 protection is most significant in the later stages of AIDS-defining illness. The same three HLA alleles are also associated with different risks for HIV transmission: hemophiliac patients with B*35Px were more likely to transmit HIV-1 to their female partners whereas patients with B*27 and B*57 were less likely to transmit the virus. The protective HLA alleles also correlate with a lower level of HIV viral loads compared to the susceptible alleles. Therefore, one mechanism to explain the observed HLA associations with AIDS is their influence on viral load control. The newly described KIR system is an important component of the innate immune mechanism. These polymorphic receptors regulate NK killing of abnormal cells through recognition of class I HLA expression. Therefore KIR may be involved in many of the diseases for which an HLA influence has been identified. Genetic epistasis between two functionally-relevant immunogenetic systems was observed: the combination of KIR3DS1 and its putative ligand HLA-Bw480I show a significant protection for AIDS progression, but either alone has no effect. Our results demonstrate that genetic polymorphisms of both acquired and innate immune systems influence AIDS pathogenesis and the disease progression. This project has been funded in whole or in part with federal funds from the National Cancer Institute, National Institutes of Health, under contract N01-CO-12400. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government.

Immune Correlates of Protection from HIV Infection and AIDS.

Recent Developments in Immune Network Theory including a concept for an HIV Vaccine

Exploring synergies between B- and T-cell vaccine approaches to optimize immune responses against HIV—workshop report

Understanding the Mechanisms and Limitations of Immune Control of HIV

Immune correlates of protection for dengue: State of the art and research agenda

Overview of HIV interactions with macrophages and dendritic cells: the other infection in AIDS

Immunopathogenic Mechanisms of HIV Infection

Recent Insights into the HIV/AIDS Pandemic

Unravelling influenza correlates of protection: lessons from human A/H1N1 Challenge

Immune activation and HIV persistence: implications for curative approaches to HIV infection

Progress of HIV-specific CTL Responses among HIV-infected Individuals

Antibody persistence and T-cell balance: Two key factors confronting HIV vaccine development

Potential contribution of gut microbiota and systemic inflammation on HIV vaccine effectiveness and vaccine design

Immunity Relation Between CD127 and HIV-1 Infection

Immune checkpoint inhibitors in infectious disease

125 Immunogenetic polymorphisms and their effects on AIDS progression:

Immune profile at HIV infection diagnosis: Evolution in the French Alps area over the last 20 years

State of the science and future directions for research on HIV and cancer: Summary of a joint workshop sponsored by IARC and NCI

Deciphering factors linked with reduced SARS-CoV-2 susceptibility in the Swiss HIV Cohort Study

25 Years after HIV Discovery: Prospects for Cure and Vaccine

Immunoregulatory molecule expression on extracellular microvesicles in people living with HIV